Growth Inhibition and Apoptosis Induction of Human Umbilical Vein Endothelial Cells by Apogossypolone |
Zhan, Yong-Hua
(School of Life Sciences and Technology, Xidian University)
Huang, Xiao-Feng (Central Laboratory, School of Basic Medicine, Fourth Military Medical University) Hu, Xing-Bin (Department of Blood Transfusion, Xijing Hospital, Fourth Military Medical University) An, Qun-Xing (Department of Blood Transfusion, Xijing Hospital, Fourth Military Medical University) Liu, Zhi-Xin (Department of Blood Transfusion, Xijing Hospital, Fourth Military Medical University) Zhang, Xian-Qing (Department of Blood Transfusion, Xijing Hospital, Fourth Military Medical University) |
1 | Abdollahi A, Lipson KE, Sckell A, et al (2003). Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res, 63, 8890-8. |
2 | Aragon-Ching JB, Madan RA, Dahut WL (2010). Angiogenesis inhibition in prostate cancer: current uses and future promises. J Oncol, 2010, 361836-42. |
3 | Arnold AA, Aboukameel A, Chen J, et al (2008). Preclinical studies of Apogossypolone: a new nonpeptidic pan smallmolecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model. Mol Cancer, 7, 20-9. DOI ScienceOn |
4 | Assadian S, El-Assaad W, Wang XQ, et al (2012). p53 inhibits angiogenesis by inducing the production of Arresten. Cancer Res, 72, 1270-9. DOI |
5 | Bagley RG, Rouleau C, Weber W, et al (2011). Tumor endothelial marker 7(TEM-7): a novel target for antiangiogenic therapy. Microvasc Res, 82, 253-62. DOI ScienceOn |
6 | Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA (1994). Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer, 73, 678-87. DOI ScienceOn |
7 | Carmeliet P, Ferreira V, Breier G, et al (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-9. DOI ScienceOn |
8 | Ebos JM, Lee CR, Cruz-Munoz W, et al (2009). Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell, 15, 232-9. DOI ScienceOn |
9 | Ferrara N, Carver-Moore K, Chen H, et al (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-42. DOI ScienceOn |
10 | Fidler IJ, Ellis LM (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79, 185-8. DOI ScienceOn |
11 | Gyftopoulos K, Vourda K, Sakellaropoulos G, et al (2011). The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade. Urol Int, 87, 464-9. DOI ScienceOn |
12 | Hanahan D (1997). Signaling vascular morphogenesis and maintenance. Science, 277, 48-50. DOI ScienceOn |
13 | Holash J, Wiegand SJ, Yancopoulos GD (1999). New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene, 18, 5356-62. DOI ScienceOn |
14 | Hood JD, Bednarski M, Frausto R, et al (2002). Tumor regression by targeted gene delivery to the neovasculature. Science, 296, 2404-7. DOI ScienceOn |
15 | Hu ZY, Zhu XF, Zhong ZD, et al (2008). ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts. Int J Cancer, 123, 2418-29. DOI ScienceOn |
16 | Konno H, Tanaka T, Matsuda I, et al (1995). Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. Int J Cancer, 61, 268-71. DOI ScienceOn |
17 | O'Reilly MS, Holmgren L, Shing Y, et al (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-28. DOI ScienceOn |
18 | Lynch TP, Ferrer CM, Jackson SR, et al (2012). Critical role of O-GlcNAc transferase in prostate cancer invasion, angiogenesis and metastasis. J Biol Chem, 287, 11070-81. DOI |
19 | Mi JX, Wang GF, Wang HB, et al (2008). Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Acta Pharmacol Sin, 29, 1467-77. DOI ScienceOn |
20 | Mucci LA, Powolny A, Giovannucci E, et al (2009). Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol, 27, 5627-33. DOI ScienceOn |
21 | Pàez-Ribes M, Allen E, Hudock J, et al (2009). Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell, 15, 220-31 DOI ScienceOn |
22 | Pande D, Negi R, Karki K, et al (2012). Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostatecarcinoma. Urol Oncol, [Epub ahead of print]. |
23 | Pinto A, Merino M, Zamora P, et al (2012). Targeting the endothelin axis in prostate carcinoma. Tumour Biol, 33, 421-6. DOI ScienceOn |
24 | Risau W (1997). Mechanisms of angiogenesis. Nature, 386, 671-4. DOI ScienceOn |
25 | Shelley MD, Hartley L, Fish RG, et al (1999). Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett, 135, 171-80. DOI ScienceOn |
26 | Sun J, Li ZM, Hu ZY, et al (2008). ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells. Anticancer Drugs, 19, 967-74. DOI ScienceOn |
27 | Zhang XQ, Huang XF, Hu XB, et al (2010b). Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. Asian J Androl, 12, 697-708. DOI ScienceOn |
28 | Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol, 143, 401-9. |
29 | Weidner N, Semple JP, Welch WR, Folkman J (1991). Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med, 324, 1-8. DOI ScienceOn |
30 | Zetter BR (1998). Angiogenesis and tumor metastasis. Annu Rev Med, 49, 407-24. DOI ScienceOn |
31 | Zhang XQ, Huang XF, Mu SJ, et al (2009). Inhibitory effect of a new gossypol derivative apogossypolone (ApoG2) on xenograft of human prostate cancer cell line PC-3. J Med Coll PLA (China), 24, 274-82. DOI ScienceOn |
32 | Zhang XQ, Huang XF, Mu SJ, et al (2010a). Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol. Asian J Androl, 12, 390-9. DOI ScienceOn |